PAR:ALBPS

Biophytis S.A. · PAR · Healthcare · EUR · FY for 2024

Figures on this page computed 2026-11-08 13:16 UTC

Last close

n/aEUR

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2024
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aNet margin
We do not hold this figure for this company, so there is nothing to place.
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2024
- Computed from the filing for 2024
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

Safety is the furthest below its sector's middle: 0.03 against 0.72 on the market's range.

Margins: n/aWe do not hold this figure for this company, so there is nothing to place.
Price: n/aWe do not hold this figure for this company, so there is nothing to place.
What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Then and now

lens 3 of 9

Five filed facts, 2015 against 2024.
Fact	2015	2024	Change
Sales	n/a	n/a	n/a
Profit	-5,232,000	-10,379,000	-98.4%
Free cash flow	-3,215,523	-8,643,000	-169%
Debt	802,792	9,842,000	+1,126%
Shares in issue	12,165	5,192,068	+42,580%

The same five facts for 2015 and 2024, each read from the year's own filing.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2015

Sales, 2015n/a
Not held.
Source
computed
Statement
income
Fiscal year
2015
Reported in
EUR
Sales, 2024n/aComputed from the filing for 2024
Not held.
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Profit, 2015-5,232,000
Source
computed
Statement
income
Fiscal year
2015
Reported in
EUR
Profit, 2024-10,379,000Computed from the filing for 2024
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Free cash flow, 2015-3,215,523
Source
computed
Statement
income
Fiscal year
2015
Reported in
EUR
Free cash flow, 2024-8,643,000Computed from the filing for 2024
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Debt, 2015802,792
Source
computed
Statement
income
Fiscal year
2015
Reported in
EUR
Debt, 20249,842,000Computed from the filing for 2024
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR
Shares in issue, 201512,165
Source
computed
Statement
income
Fiscal year
2015
Reported in
EUR
Shares in issue, 20245,192,068Computed from the filing for 2024
Source
computed
Statement
income
Fiscal year
2024
Reported in
EUR